Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2HVX

Discovery of Potent, Orally Active, Nonpeptide Inhibitors of Human Mast Cell Chymase by Using Structure-Based Drug Design

2HVX の概要
エントリーDOI10.2210/pdb2hvx/pdb
分子名称Chymase, [(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID (3 entities in total)
機能のキーワードserine protease, hydrolase
由来する生物種Homo sapiens (human)
細胞内の位置Secreted: P23946
タンパク質・核酸の鎖数1
化学式量合計25423.69
構造登録者
主引用文献Greco, M.N.,Hawkins, M.J.,Powell, E.T.,Almond, H.R.,de Garavilla, L.,Hall, J.,Minor, L.K.,Wang, Y.,Corcoran, T.W.,Di Cera, E.,Cantwell, A.M.,Savvides, S.N.,Damiano, B.P.,Maryanoff, B.E.
Discovery of potent, selective, orally active, nonpeptide inhibitors of human mast cell chymase.
J.Med.Chem., 50:1727-1730, 2007
Cited by
PubMed Abstract: A series of beta-carboxamido-phosphon(in)ic acids (2) was identified as a new structural motif for obtaining potent inhibitors of human mast cell chymase. For example, 1-naphthyl derivative 5f had an IC50 value of 29 nM and (E)-styryl derivative 6g had an IC50 value of 3.5 nM. An X-ray structure for 5f.chymase revealed key interactions within the enzyme active site. Compound 5f was selective for inhibiting chymase versus eight serine proteases. Compound 6h was orally bioavailable in rats (F=39%), and orally efficacious in a hamster model of inflammation.
PubMed: 17361995
DOI: 10.1021/jm0700619
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.6 Å)
構造検証レポート
Validation report summary of 2hvx
検証レポート(詳細版)ダウンロードをダウンロード

251801

件を2026-04-08に公開中

PDB statisticsPDBj update infoContact PDBjnumon